Literature DB >> 3145516

Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.

J B Burch1, C M de Fiebre, M J Marks, A C Collins.   

Abstract

Female DBA/2Ibg mice were treated chronically (21 days) with ethanol- or dextrin-containing liquid diets or infused chronically with nicotine (8 mg/kg/h) or saline for 10 days. The responses of these animals to challenge doses of ethanol (2.5 g/kg) or nicotine (1 or 2 mg/kg) were measured using a test battery consisting of respiration rate, acoustic startle response, Y-maze crosses and rears, heart rate and body temperature. Chronic ethanol-treated animals were tolerant to the effects elicited by a challenge dose of ethanol on four of the six measures and were cross-tolerant to nicotine's effects on the acoustic startle test. Chronic nicotine-treated animals were tolerant to nicotine's effects on five of the six measures and cross-tolerant to ethanol's effects on heart rate and body temperature. Thus, partial cross-tolerance between ethanol and nicotine exists. Chronic nicotine treatment resulted in significant increases in L-[3H]-nicotine binding in six of seven brain regions and in alpha-[125I]-bungarotoxin binding in three of seven brain regions. Chronic ethanol treatment failed to alter the binding of either ligand. Therefore, the cross-tolerance that develops between ethanol and nicotine is not totally dependent on alterations in the number of brain nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145516     DOI: 10.1007/bf00172954

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Facilitation of human tobacco self-administration by ethanol: a behavioral analysis.

Authors:  R R Griffiths; G E Bigelow; I Liebson
Journal:  J Exp Anal Behav       Date:  1976-05       Impact factor: 2.468

2.  Smoking and alcoholism: a brief report.

Authors:  R G Walton
Journal:  Am J Psychiatry       Date:  1972-05       Impact factor: 18.112

3.  Effects of ethanol on cigarette smoking by volunteers without histories of alcoholism.

Authors:  J E Henningfield; L D Chait; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Cigarette smoking by women: interactions with alcohol use.

Authors:  N K Mello; J H Mendelson; S L Palmieri
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Co-occurrent use of cigarettes, alcohol, and coffee in healthy, community-living men and women.

Authors:  T P Carmody; C S Brischetto; J D Matarazzo; R P O'Donnell; W E Connor
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

6.  Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine.

Authors:  P Gothóni; W Ikola
Journal:  Med Biol       Date:  1985

7.  Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.

Authors:  M J Marks; J A Stitzel; E Romm; J M Wehner; A C Collins
Journal:  Mol Pharmacol       Date:  1986-11       Impact factor: 4.436

8.  Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol.

Authors:  P Gothóni
Journal:  Med Biol       Date:  1983

9.  Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.

Authors:  M J Marks; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

10.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  14 in total

Review 1.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

Review 2.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 3.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

4.  Repeated exposure of the posterior ventral tegmental area to nicotine increases the sensitivity of local dopamine neurons to the stimulating effects of ethanol.

Authors:  Zheng-Ming Ding; Simon N Katner; Zachary A Rodd; William Truitt; Sheketha R Hauser; Gerald A Deehan; Eric A Engleman; William J McBride
Journal:  Alcohol       Date:  2012-03-25       Impact factor: 2.405

Review 5.  Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence.

Authors:  Sally Adams
Journal:  Curr Addict Rep       Date:  2017-02-18

Review 6.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

7.  Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study.

Authors:  Sterling M McPherson; Ekaterina Burduli; Crystal Lederhos Smith; Olivia Brooks; Michael F Orr; Celestina Barbosa-Leiker; Trynke Hoekstra; Michael G McDonell; Sean M Murphy; Matthew Layton; John M Roll
Journal:  Exp Clin Psychopharmacol       Date:  2018-08-27       Impact factor: 3.157

Review 8.  The genetic components of alcohol and nicotine co-addiction: from genes to behavior.

Authors:  Isabel R Schlaepfer; Nicole R Hoft; Marissa A Ehringer
Journal:  Curr Drug Abuse Rev       Date:  2008-06

9.  A prospective study of the effects of cigarette smoking and alcohol abuse on mortality.

Authors:  G E Vaillant; P P Schnurr; J A Baron; P D Gerber
Journal:  J Gen Intern Med       Date:  1991 Jul-Aug       Impact factor: 5.128

Review 10.  Individual variability in responses to nicotine.

Authors:  K A Perkins
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.